JAK Kinase Inhibition Abrogates STAT3 Activation and Head and Neck Squamous Cell Carcinoma Tumor Growth()()

Aberrant activation of the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) 3 has been implicated in cell proliferation and survival of many cancers including head and neck squamous cell carcinoma (HNSCC). AZD1480, an orally active pharmacologic inhibitor of JAK1/JAK2, has...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neoplasia
Main Authors: Sen, Malabika, Pollock, Netanya I., Black, John, DeGrave, Kara A., Wheeler, Sarah, Freilino, Maria L., Joyce, Sonali, Lui, Vivian W.Y., Zeng, Yan, Chiosea, Simion I., Grandis, Jennifer R.
Formato: Artigo
Idioma:Inglês
Publicado: Neoplasia Press 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4372647/
https://ncbi.nlm.nih.gov/pubmed/25810010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2015.01.003
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares